Loading company…
Persist AI automates drug formulation development with robotics and machine learning.
Persist AI provides automated formulation screening, drug release testing, method transfer and manufacturing scale-up services. Its capabilities include formulation, sterilization, scale-up and stability testing using robotics and machine learning. Founded in 2022 by Christopher Shelner and Karthik Raman, the company is based in California, US. In May 2025, it raised USD 12 million in Series A funding led by Spero Ventures, with 2048 Ventures, Innospark Ventures, Y Combinator and other investors participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in